Connection

Claus Bachert to Sinusitis

Back to Details
This is a "connection" page, showing publications Claus Bachert has written about Sinusitis.
Claus Bachert
Connection Strength
8.194
Sinusitis
  1. The GALEN rhinosinusitis cohort: chronic rhinosinusitis with nasal polyps affects health-related quality of life. Rhinology. 2019 Oct 01; 57(5):343-351.
    View in: PubMed
    Score: 0.457
  2. Chronic Rhinosinusitis with Nasal Polyps in Older Adults: Clinical Presentation, Pathophysiology, and Comorbidity. Curr Allergy Asthma Rep. 2019 09 05; 19(10):46.
    View in: PubMed
    Score: 0.455
  3. Cross-talk between TH2 and TH17 pathways in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2019 11; 144(5):1254-1264.
    View in: PubMed
    Score: 0.449
  4. Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma. J Allergy Clin Immunol Pract. 2019 Sep - Oct; 7(7):2447-2449.e2.
    View in: PubMed
    Score: 0.441
  5. The Global Allergy and Asthma European Network (GALEN rhinosinusitis cohort: a large European cross-sectional study of chronic rhinosinusitis patients with and without nasal polyps. Rhinology. 2019 Feb 01; 57(1):32-42.
    View in: PubMed
    Score: 0.437
  6. Endoscopic Sinus Surgery for Type-2 CRS wNP: An Endotype-Based Retrospective Study. Laryngoscope. 2019 06; 129(6):1286-1292.
    View in: PubMed
    Score: 0.436
  7. Innate lymphoid cells in the upper airways: importance of CD117 and IL-1RI expression. Eur Respir J. 2018 12; 52(6).
    View in: PubMed
    Score: 0.432
  8. Chronic rhinosinusitis with nasal polyps is characterized by dysbacteriosis of the nasal microbiota. Sci Rep. 2018 05 21; 8(1):7926.
    View in: PubMed
    Score: 0.416
  9. Endotype-driven care pathways in patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2018 05; 141(5):1543-1551.
    View in: PubMed
    Score: 0.415
  10. Serum periostin, IgE, and SE-IgE can be used as biomarkers to identify moderate to severe chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2017 12; 140(6):1705-1708.e3.
    View in: PubMed
    Score: 0.396
  11. Biotherapeutics in Chronic Rhinosinusitis with and without Nasal Polyps. J Allergy Clin Immunol Pract. 2017 Nov - Dec; 5(6):1512-1516.
    View in: PubMed
    Score: 0.388
  12. Extracellular eosinophilic traps in association with Staphylococcus aureus at the site of epithelial barrier defects in patients with severe airway inflammation. J Allergy Clin Immunol. 2017 Jun; 139(6):1849-1860.e6.
    View in: PubMed
    Score: 0.381
  13. Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis. J Allergy Clin Immunol. 2015 Dec; 136(6):1431-1440.
    View in: PubMed
    Score: 0.351
  14. Treatment of acute rhinosinusitis with the preparation from Pelargonium sidoides EPs 7630: a randomized, double-blind, placebo-controlled trial. Rhinology. 2009 Mar; 47(1):51-8.
    View in: PubMed
    Score: 0.220
  15. Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paper. Allergy. 2021 03; 76(3):677-688.
    View in: PubMed
    Score: 0.126
  16. COVID-19 in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab. J Allergy Clin Immunol. 2020 Jul; 146(1):218-220.e2.
    View in: PubMed
    Score: 0.119
  17. Laryngorhinootologie. 2020 06; 99(6):356-364.
    View in: PubMed
    Score: 0.119
  18. Patient Advisory Board for Chronic Rhinosinusitis - A EUFOREA initiative. Rhinology. 2019 Oct 01; 57(5):331-335.
    View in: PubMed
    Score: 0.114
  19. EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis. Rhinology. 2019 06 01; 57(3):162-168.
    View in: PubMed
    Score: 0.112
  20. Medication use in patients with chronic rhinosinusitis in Germany - a large retrospective patient-based study. Rhinology. 2019 Apr 01; 57(2):94-100.
    View in: PubMed
    Score: 0.110
  21. Current healthcare pathways in the treatment of rhinosinusitis in Germany. Acta Otolaryngol. 2018 Dec; 138(12):1086-1091.
    View in: PubMed
    Score: 0.109
  22. IFN-?1 enhances Staphylococcus aureus clearance in healthy nasal mucosa but not in nasal polyps. J Allergy Clin Immunol. 2019 04; 143(4):1416-1425.e4.
    View in: PubMed
    Score: 0.108
  23. Risk factors for post-9/11 chronic rhinosinusitis in Fire Department of the City of New York workers. Occup Environ Med. 2018 12; 75(12):884-889.
    View in: PubMed
    Score: 0.107
  24. Highlights of eosinophilic chronic rhinosinusitis with nasal polyps in definition, prognosis, and advancement. Int Forum Allergy Rhinol. 2018 11; 8(11):1218-1225.
    View in: PubMed
    Score: 0.107
  25. mySinusitisCoach: patient empowerment in chronic rhinosinusitis using mobile technology. Rhinology. 2018 Sep 01; 56(3):209-215.
    View in: PubMed
    Score: 0.106
  26. Rhinology Future Debates 2017 by EUFOREA: Novel treatments and surgical solutions in rhinology. Clin Otolaryngol. 2018 12; 43(6):1429-1438.
    View in: PubMed
    Score: 0.105
  27. Staphylococcus aureus enhances the tight junction barrier integrity in healthy nasal tissue, but not in nasal polyps. J Allergy Clin Immunol. 2018 08; 142(2):665-668.e8.
    View in: PubMed
    Score: 0.103
  28. Activation of Activin receptor-like kinases curbs mucosal inflammation and proliferation in chronic rhinosinusitis with nasal polyps. Sci Rep. 2018 01 24; 8(1):1561.
    View in: PubMed
    Score: 0.102
  29. Ectopic lymphoid tissues support local immunoglobulin production in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2018 03; 141(3):927-937.
    View in: PubMed
    Score: 0.101
  30. Rhinology Future Debates, an EUFOREA Report. Rhinology. 2017 Dec 01; 55(4):298-304.
    View in: PubMed
    Score: 0.101
  31. IL-21 Is Increased in Nasal Polyposis and after Stimulation with Staphylococcus aureus Enterotoxin B. Int Arch Allergy Immunol. 2017; 174(3-4):161-169.
    View in: PubMed
    Score: 0.100
  32. Chronic rhinosinusitis in Asia. J Allergy Clin Immunol. 2017 Nov; 140(5):1230-1239.
    View in: PubMed
    Score: 0.100
  33. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis. Rhinology. 2017 Sep 01; 55(3):202-210.
    View in: PubMed
    Score: 0.099
  34. The effect of systemic treatments on periostin expression reflects their interference with the eosinophilic inflammation in chronic rhinosinusitis with nasal polyps. Rhinology. 2017 Jun 01; 55(2):152-160.
    View in: PubMed
    Score: 0.097
  35. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. Allergy. 2017 Sep; 72(9):1297-1305.
    View in: PubMed
    Score: 0.097
  36. Programmed cell death-1 expression correlates with disease severity and IL-5 in chronic rhinosinusitis with nasal polyps. Allergy. 2017 Jun; 72(6):985-993.
    View in: PubMed
    Score: 0.096
  37. The relation of airway obstruction to asthma, chronic rhinosinusitis and age: results from a population survey of adults. Allergy. 2014 Sep; 69(9):1205-14.
    View in: PubMed
    Score: 0.080
  38. Rhinosinusitis: Developing guidance for clinical trials. Otolaryngol Head Neck Surg. 2006 Nov; 135(5 Suppl):S31-80.
    View in: PubMed
    Score: 0.047
  39. Conjunctivitis in dupilumab clinical trials. Br J Dermatol. 2019 09; 181(3):459-473.
    View in: PubMed
    Score: 0.028
  40. IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy. J Allergy Clin Immunol Pract. 2019 May - Jun; 7(5):1418-1429.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.